Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Trading Statement

21 Mar 2019 07:00

RNS Number : 5086T
Halma PLC
21 March 2019
 

Halma, the leading safety, health and environmental technology group, today releases its trading update, for the period from 1 October 2018 to date.

 

Halma has made good progress in the period. Based on current trading and forecasts, the Board expects adjusted profit before tax for the year ending 31 March 2019 to be in line with market consensus expectations (see notes 1 and 2).

 

There has been widespread revenue growth geographically. The USA and the UK have seen the strongest growth, with more moderate growth in Mainland Europe and Asia Pacific. Order intake has remained ahead of revenue and the same period last year. There has been a positive currency translation effect on Group revenue and profit in the second half, resulting in a broadly neutral effect for the year as a whole.

 

The Safety sectors have performed in line with expectations, with the strongest progress in Infrastructure Safety, supported by positive contributions from recent acquisitions. Process Safety is expected to deliver a satisfactory performance for the full year despite planned reorganisation costs in the second half. The Medical and Environmental & Analysis sectors remain on track to deliver good full-year performances.

 

We made three acquisitions in the second half, all in Infrastructure Safety, for a total initial consideration of approximately £62 million. The acquisitions of Limotec and Navtech were reported in the Group's half year results announcement. In January 2019, we announced the acquisition of Rath Communications, a provider of emergency communication systems for Areas of Refuge in the USA, for US$42.4 million (£32.6 million). The integrations of all acquisitions made during the year are progressing well, and the acquisition pipeline remains healthy in all four sectors.

 

The Group's financial position is robust and cash generation remains strong, supporting investment in both organic and acquisitive growth.

 

The results for the year ending 31 March 2019 will be released on 11 June 2019.

 

For further information, please contact:

 

Halma plc

Andrew Williams, Chief Executive

Switchboard: +44 (0)1494 721111

Marc Ronchetti, Chief Financial Officer

Charles King, Head of Investor Relations

Mobile: +44 (0)7776 685948

 

MHP Communications

Rachel Hirst/ Andrew Jaques

+44 (0)20 3128 8100

 

About Halma

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner and healthier future for people worldwide. Our innovative products and solutions address many of the key issues facing the world today. We operate in four sectors: Process Safety, Infrastructure Safety, Medical and Environmental & Analysis. We employ over 6,000 people in more than 20 countries, with major operations in Europe, the USA and Asia-Pacific. We target global niche markets where sustainable growth and high returns are supported by long-term drivers. Halma is listed on the London Stock Exchange and has been a member of the FTSE 100 index since December 2017.

 

Notes

 

1. Adjusted profit before tax is before amortisation and impairment of acquired intangible assets, acquisition items, restructuring costs and profit or loss on disposal of businesses.

 

2. The Board believes current market forecasts for adjusted profit before tax for the year ending 31 March 2019 to be in the range of £240.1 million to £253.4 million, with a consensus of £243.7m.

 

3. This Trading Update is based upon management accounts information. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

4. A copy of this announcement, together with other information about Halma, may be viewed on our website www.halma.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBIGDXDXDBGCG
Date   Source Headline
15th Oct 20211:06 pmRNSDirector/PDMR Shareholding
4th Oct 20212:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20211:01 pmRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading update
9th Sep 202110:22 amRNSDirector Declaration
9th Aug 20217:00 amRNSM&A Update
26th Jul 202111:01 amRNSDirector/PDMR Shareholding
22nd Jul 20213:00 pmRNSResult of AGM
5th Jul 20214:05 pmRNSDirector/PDMR Shareholding
30th Jun 20211:50 pmRNSDirector/PDMR Shareholding
23rd Jun 20214:47 pmRNSAnnual Financial Report
10th Jun 20217:01 amRNSUnaudited restated segmental information
10th Jun 20217:00 amRNSFull Year Results 2021
27th Apr 20217:00 amRNSAcquisition
26th Mar 20217:00 amRNSAppointment of independent non-executive Director
24th Mar 20217:00 amRNSTrading update
23rd Feb 20217:54 amRNSDirector Declaration
10th Feb 20214:52 pmRNSDirector/PDMR Shareholding
9th Feb 20217:00 amRNSDirectorate Change
21st Dec 20202:00 pmRNSAcquisition
18th Dec 20207:00 amRNSDisposal
4th Dec 20207:04 amRNSDirector Declaration
2nd Dec 20204:08 pmRNSDirector/PDMR Shareholding
25th Nov 20203:20 pmRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSHALF YEAR RESULTS 2020/21
5th Oct 20201:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:05 amRNSDirector Declaration
23rd Sep 20207:00 amRNSChair retirement
23rd Sep 20207:00 amRNSTrading update
4th Sep 20204:57 pmRNSResult of AGM
31st Jul 20204:06 pmRNSDirector/PDMR Shareholding
24th Jul 20205:02 pmRNSAnnual Financial Report
17th Jul 20209:32 amRNSDirector/PDMR Shareholding
14th Jul 20207:00 amRNSFinal Results
15th May 20201:29 pmRNSElectronic Communications with Shareholders
27th Apr 202012:46 pmRNSDisclosure of Rights Attached to Equity Shares
21st Apr 20207:00 amRNSCOVID-19 Update
2nd Apr 20207:05 amRNSExecutive Board changes
19th Mar 20207:00 amRNSTrading Statement
5th Mar 20209:00 amRNSInvestor Event
24th Feb 202011:31 amRNSHolding(s) in Company
21st Feb 20207:00 amRNSAcquisition
5th Feb 20207:00 amRNSAcquisition
27th Jan 20207:00 amRNSAcquisition
22nd Jan 202012:58 pmRNSChange of Remuneration Committee Chair
29th Nov 20191:27 pmRNSDirector/PDMR Shareholding
25th Nov 20195:10 pmRNSDirector/PDMR Shareholding
19th Nov 201911:45 amRNSDividend Declaration
19th Nov 20197:00 amRNSHalf-year Report
2nd Oct 20195:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.